Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The IsraelIRLCF -13.45%65 ROE % is 8.29% as of Mar. 2026, which is 4% below its 10-year median of 8.62. GuruFocus rates IRLCF with a GF Score™ of 65/100 and a GF Value™ of $273.43. The stock has 5 warning signs investors should review. Among 1,584 Chemicals companies, The Israel ranks worse than 58.46% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. The Israel's annualized net income for the quarter that ended in Mar. 2026 was $252 Mil. The Israel's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was $3,041 Mil. Therefore, The Israel's annualized ROE % for the quarter that ended in Mar. 2026 was 8.29%.
The historical rank and industry rank for The Israel's ROE % or its related term are showing as below:
IRLCF'
s ROE % Range Over the Past 10 Years
Min: -13.14 Med: 8.62 Max: 47.72
Current: 3.83
During the past 13 years, The Israel's highest ROE % was 47.72%. The lowest was -13.14%. And the median was 8.62%.
IRLCF's ROE % is ranked worse than 58.46% of 1584
companies
in the Chemicals industry
Industry Median: 5.25
vs IRLCF: 3.83
The Israel (OTCPK:IRLCF) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
The Israel ROE % Related Terms
The Israel ROE % Historical Data
* Premium members only.
The historical data trend for The Israel's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, The Israel's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Israel ROE % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, The Israel's ROE % distribution charts can be found below:
* The bar in red indicates where The Israel's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
The Israel (IRLCF) has a ROE % of 8.29% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on The Israel and its competitors. This is near median its historical median of 8.62. According to the industry distribution chart, The Israel ranks #926 out of 1584 companies in the Chemicals industry, placing it in the top 58.5%.
Is The Israel's ROE % too high?
The Israel's current ROE % of 8.29% is near median its 10-year median of 8.62. The Chemicals industry median ROE % is 5.25. The Israel's value of 8.29% is 57.9% above this industry median. Based on the distribution chart, The Israel ranks #926 out of 1584 companies in the Chemicals industry, which is below the industry midpoint. Overall, The Israel has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does The Israel's ROE % compare to LIN and SHW?
According to the Chemicals industry distribution chart, The Israel ranks #926 out of 1584 companies for ROE %. This places The Israel in the lower half of its industry. The industry median ROE % is 5.25. The Israel's value of 8.29% is 57.9% above this benchmark. While the company's 10-year median is 8.62 vs. the industry median of 5.25, The Israel has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Chemicals company?
The median ROE % among Chemicals companies is 5.25, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Israel's current ROE % of 8.29% is 57.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on The Israel and its competitors. For the Chemicals industry, the median ROE % is 5.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Israel's current ROE % is 8.29%, which is near median its own 10-year median of 8.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Israel stock overvalued right now?
The Israel (IRLCF) has a current ROE % of 8.29%. The stock's GF Value™ is $273.43, compared to a current price of $238.00 — trading 13% below its estimated fair value. The current ROE % is 8.29%, which is near median its 10-year median of 8.62 and 57.9% above the Chemicals industry median of 5.25. The Israel's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For The Israel (IRLCF), the current ROE % is 8.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Israel (IRLCF) Overvalued in 2026?
Based on GuruFocus' analysis, The Israel stock appears to be undervalued.
The current stock price of $238.00 is trading 13% below its estimated GF Value™ of $273.43.
Key valuation signals for IRLCF:
ROE %: 8.29% (near median its 10-year median of 8.62)
GF Value™: $273.43 vs. price of $238.00 (13% below fair value)
Industry Position: 57.9% above the Chemicals median (#926 of 1584)
No single metric tells the full story. See the IRLCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Israel Corp Ltd is a holding company. Along with its subsidiaries, it operates as a specialty minerals and chemicals company creating solutions to challenges in the food, agriculture, and industrial markets by leveraging its bromine, potash, and phosphate resources. The group operates through the following segments: Industrial Products (Bromine), Potash, Phosphate Solutions, and Growing Solutions. Maximum revenue is generated from its Phosphate Solutions segment, which manufactures phosphoric acid, sulphuric acid, green phosphoric acid, and phosphate fertilizers through its mines and facilities in Israel and China. Geographically, the group generates maximum revenue from Israel, followed by Europe, South America, North America, Asia, and other regions.
65GF Score
Get the complete analysis for IRLCF
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRLCF has been successfully added to your 
